Stay updated on Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-12T00:00:41.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government funding lapse notice (Revision: v3.4.1) on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:20:07.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The study record is updated to Completed with related identifiers and dates added. New data-sharing resources are linked (ProcedureAccessClinicalTrialData.pdf and external data sharing site), and the old Active, not recruiting status was removed.
    Difference
    0.9%
    Check dated 2026-02-04T06:38:45.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page adds a glossary toggle, updates labeling for 'Last Update Submitted' and 'No FEAR Act Data' capitalization, and increments the revision to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:20:06.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision note added: v3.3.4 was introduced and v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:14:37.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Footer revision updated to Revision: v3.3.3 and the HHS Vulnerability Disclosure link removed, along with the Revision: v3.3.2 note. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T10:15:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.